Let7b-5p is Upregulated in the Serum of Emirati Patients with Type 2 Diabetes and Regulates Insulin Secretion in INS-1 Cells

Abstract

Let7b-5p is a member of the Let-7 miRNA family and one of the top expressed miRNAs in human islets that implicated in glucose homeostasis. The levels of Let7b-5p in type 2 diabetes (T2DM) patients or its role in β-cell function is still unclear. In the current study, we measured the serum levels of let7b-5p in Emirati patients with T2DM (with/without complications) and control subjects. Overexpression or silencing of let7b-5p in INS-1 (832/13) cells was performed to investigate the impact on insulin secretion, content, cell viability, apoptosis, and key functional genes. We found that serum levels of let7b-5p are significantly (p<0.05) higher in T2DM-patients or T2DM with complications compared to control subjects. Overexpression of let7b-5p increased insulin content and decreased glucose-stimulated insulin secretion, whereas silencing of let7b-5p reduced insulin content and secretion. Modulation of the expression levels of let7b-5p did not influence cell viability nor apoptosis. Analysis of mRNA and protein expression of hallmark genes in let7b-5p transfected cells revealed a marked dysregulation of Insulin, Pancreatic And Duodenal Homeobox 1 (PDX1), glucokinase (GCK), glucose transporter 2 (GLUT2), and INSR. In conclusion, an appropriate level of let7b-5p is essential to maintain β-cell function and may be regarded as a biomarker for T2DM.

Key words

Diabetes - Autoimmunity - Let7b-5p. - INS-1 (832/31) - miRNA

Publication History

Received: 17 March 2020
Received: 09 June 2020

Accepted: 11 September 2020

Article published online:
09 October 2020

• References

• 1 van de Bunt M, Gaulton KJ, Parts L. et al. The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis. PLoS One 2013; 8: e55272
• 2 Boyerinas B, Park SM, Hau A. et al. The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 2010; 17: F19-F36
• 3 Johnson SM, Grosshans H, Shingara J. et al. RAS is regulated by the let-7 microRNA family. Cell 2005; 120: 635-647
• 4 Kumar MS, Erkeland SJ, Pester RE. et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA 2008; 105: 3903-3908
• 5 Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 2007; 21: 1025-1030
• 6 Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007; 315: 1576-1579
• 7 Pasquinelli AE, Reinhart BJ, Slack F. et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000; 408: 86-89
• 8 Ruby JG, Jan C, Player C. et al. Large-scale sequencing reveals 21U-RNAs and additional microRNAs and endogenous siRNAs in C. elegans. Cell 2006; 127: 1193-1207
• 9 LaPierre MP, Stoffel M. MicroRNAs as stress regulators in pancreatic beta cells and diabetes. Mol Metab 2017; 6: 1010-1023
• 10 Nesca V, Guay C, Jacovetti C. et al. Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes. Diabetologia 2013; 56: 2203-2212
• 11 Roggli E, Britan A, Gattesco S. et al. Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic β-Cells. Diabetes 2010; 59: 978-986
• 12 van de Bunt M, Gloyn AL. A tale of two glucose transporters: how GLUT2 re-emerged as a contender for glucose transport into the human beta cell. Diabetologia 2012; 55: 2312-2315
• 13 Frost RJ, Olson EN. Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs. Proc Natl Acad Sci USA 2011; 108: 21075-21080
• 14 Williams MD, Mitchell GM. MicroRNAs in insulin resistance and obesity. Exp Diabetes Res 2012; 2012: 484696
• 15 Zhu H, Shyh-Chang N, Segrè AV. et al. The Lin28/let-7 axis regulates glucose metabolism. Cell 2011; 147: 81-94
• 16 Ideozu JE, Zhang X, Rangaraj V. et al. Microarray profiling identifies extracellular circulating miRNAs dysregulated in cystic fibrosis. Sci Rep 2019; 9: 15483
• 17 Qattan A, Intabli H, Alkhayal W. et al. Robust expression of tumor suppressor miRNA’s let-7 and miR-195 detected in plasma of Saudi female breast cancer patients. BMC Cancer 2017; 17: 799
• 18 Zedan AH, Hansen TF, Assenholt J. et al. microRNA expression in tumour tissue and plasma in patients with newly diagnosed metastatic prostate cancer. Tumour Biol 2018; 40: 1010428318775864
• 19 Zou X, Wei J, Huang Z. et al. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis. Cancer Med 2019; 8: 2810-2822
• 20 Meerson A, Najjar A, Saad E. et al. Sex differences in plasma microrna biomarkers of early and complicated diabetes mellitus in Israeli Arab and Jewish Patients. Noncoding RNA 2019; 5: 32-43
• 21 Pasquier J, Ramachandran V, Abu-Qaoud MdR. et al. Differentially expressed circulating microRNAs in the development of acute diabetic Charcot foot. Epigenomics 2018; 10: 1267-1278
• 22 Catanzaro G, Besharat ZM, Chiacchiarini M. et al. Circulating microRNAs in elderly type 2 diabetic patients. Int J Endocrinol 2018; 2018: 6872635-6872635
• 23 Kokkinopoulou I, Maratou E, Mitrou P. et al. Decreased expression of microRNAs targeting type-2 diabetes susceptibility genes in peripheral blood of patients and predisposed individuals. Endocrine 2019; 66: 226-239
• 24 Elhelw DS, Mekky RY, El-Ekiaby N. et al. Predictive prognostic role of miR‑181a with discrepancy in the liver and serum of genotype 4 hepatitis C virus patients. Biomed Rep 2014; 2: 843-848
• 25 Taneera J, Dhaiban S, Hachim M et al. Reduced expression of Chl1 gene impairs insulin secretion by down-regulating the expression of key molecules of β-cell function. Exp Clin Endocrinol Diabetes 2019: (EFirst)
• 26 Xu H, Liu C, Zhang Y. et al. Let-7b-5p regulates proliferation and apoptosis in multiple myeloma by targeting IGF1R. Acta Biochim Biophys Sin 2014; 46: 965-972
• 27 Huang RS, Gamazon ER, Ziliak D. et al. Population differences in microRNA expression and biological implications. RNA Biol 2011; 8: 692-701
• 28 Osella M, Riba A, Testori A. et al. Interplay of microRNA and epigenetic regulation in the human regulatory network. Front Genet 2014; 5: 345-355
• 29 Theodore SC, Rhim JS, Turner T. et al. MiRNA 26a expression in a novel panel of African American prostate cancer cell lines. Ethn Dis 2010; 20: S1
• 30 Saito Y, Liang G, Egger G. et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006; 9: 435-443
• 31 Castellano L, Giamas G, Jacob J. et al. The estrogen receptor-α-induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci USA 2009; 106: 15732-15737
• 32 Fletcher CE, Dart DA, Bevan CL. Interplay between steroid signalling and microRNAs: Implications for hormone-dependent cancers. Endocr Relat Cancer 2014; 21: R409-R429
• 33 Greenblatt RB, Oettinger M, Bohler CS. Estrogen-androgen levels in aging men and women: Therapeutic considerations. J Am Geriatr Soc 1976; 24: 173-178
• 34 Klinge CM. Estrogen regulation of microRNA expression. Curr Genomics 2009; 10: 169-183
• 35 Klinge CM. miRNAs and estrogen action. Trends Endocrinol Metab 2012; 23: 223-233
• 36 Wang Y-T, Tsai P-C, Liao Y-C. et al. Circulating microRNAs have a sex-specific association with metabolic syndrome. J Biomed Sci 2013; 20: 72
• 37 Cho S, Mutlu L, Grechukhina O. et al. Circulating microRNAs as potential biomarkers for endometriosis. Fertil Steril 2015; 103: 1252.e1251-1260.e1251
• 38 Seifer BJ, Su D, Taylor HS. Circulating miRNAs in murine experimental endometriosis: decreased abundance of let-7a. Reprod Sci 2017; 24: 376-381
• 39 Bollheimer LC, Skelly RH, Chester MW. et al. Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J Clin Invest 1998; 101: 1094-1101
• 40 Eto K, Yamashita T, Tsubamoto Y. et al. Phosphatidylinositol 3-kinase suppresses glucose-stimulated insulin secretion by affecting post-cytosolic [Ca2+] elevation signals. Diabetes 2002; 51: 87-97
• 41 Lenzen S. A fresh view of glycolysis and glucokinase regulation: history and current status. J Biol Chem 2014; 289: 12189-12194
• 42 Schuit FC, Huypens P, Heimberg H. et al. Glucose sensing in pancreatic beta-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. Diabetes 2001; 50: 1-11
• 43 Thorens B, Guillam MT, Beermann F. et al. Transgenic reexpression of GLUT1 or GLUT2 in pancreatic beta cells rescues GLUT2-null mice from early death and restores normal glucose-stimulated insulin secretion. J Biol Chem 2000; 275: 23751-23758